Provided by Tiger Fintech (Singapore) Pte. Ltd.

Belite Bio, Inc.

56.40
-0.8800-1.54%
Post-market: 56.400.00000.00%18:23 EDT
Volume:20.44K
Turnover:1.16M
Market Cap:1.80B
PE:-47.65
High:58.01
Open:56.76
Low:55.51
Close:57.28
Loading ...

Belite Bio Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
28 Jan

Benchmark Co. Keeps Their Buy Rating on Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
21 Jan

Breakeven On The Horizon For Belite Bio, Inc (NASDAQ:BLTE)

Simply Wall St.
·
21 Jan

Belite Bio Inc : Benchmark Raises Target Price to $79 From $57

THOMSON REUTERS
·
21 Jan

Lin Bioscience Receives U.S. FDA Fast Track Designation for Lbs-007

THOMSON REUTERS
·
27 Nov 2024

Belite Bio price target raised to $110 from $60 at Maxim

TIPRANKS
·
15 Nov 2024

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Mereo Biopharma Group Plc (MREO) and Fate Therapeutics (FATE)

TIPRANKS
·
14 Nov 2024

Belite Bio Advances in Tinlarebant Trials, Appoints New CMO

TIPRANKS
·
12 Nov 2024

Belite Bio Q3 Net Loss Narrows

MT Newswires Live
·
12 Nov 2024

Belite Bio Q3 2024 GAAP EPS $(0.28) Beats $(0.29) Estimate, Cash $109M

Benzinga
·
12 Nov 2024

Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

THOMSON REUTERS
·
12 Nov 2024

Belite Bio Q3 Income From Operations USD -9.74 Million

THOMSON REUTERS
·
12 Nov 2024

Belite Bio Q3 Pretax Profit USD -8.679 Million

THOMSON REUTERS
·
12 Nov 2024

Press Release: Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

Dow Jones
·
12 Nov 2024

Belite Bio Offers New Warrant Opportunities to Investors

TIPRANKS
·
04 Nov 2024

Belite Bio Raises $28.8 Million After Warrants Exercised

MT Newswires Live
·
04 Nov 2024

BRIEF-Belite Bio Announces Exercise Of Warrants For US$28.75 Million Gross Proceeds

Reuters
·
04 Nov 2024

Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds

THOMSON REUTERS
·
04 Nov 2024